Form 8-K - Current report:
SEC Accession No. 0000950170-25-065618
Filing Date
2025-05-07
Accepted
2025-05-07 16:05:10
Documents
13
Period of Report
2025-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rvmd-20250507.htm   iXBRL 8-K 46800
2 EX-99.1 rvmd-ex99_1.htm EX-99.1 155625
3 GRAPHIC img162218922_0.jpg GRAPHIC 262132
  Complete submission text file 0000950170-25-065618.txt   721084

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rvmd-20250507.xsd EX-101.SCH 44644
15 EXTRACTED XBRL INSTANCE DOCUMENT rvmd-20250507_htm.xml XML 6270
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

EIN.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39219 | Film No.: 25921205
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)